Medical Condition News

RSS

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Melanoma incidence and mortality may eventually decrease among the entire Swedish population

Researchers assess the incidence of melanoma and mortality trends among younger patients.

13 Sep 2024

Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Researchers examine how the COVID-19 pandemic affected cancer diagnosis rates between 2021 and 2020.

13 Sep 2024

Significant global cardiovascular risk linked to high lipoprotein(a) levels

Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested for and possibly treated.

12 Sep 2024

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

Researchers examine the role of GLP-2 in regulating food intake through its effects on gastrointestinal motility and satiety signals, offering insights into potential obesity treatments.

12 Sep 2024

New gene variants linked to early menopause and cancer risk identified

Study reveals nine gene variants linked to ovarian aging and cancer risk, with implications for reproductive longevity and de novo mutation rates.

12 Sep 2024

New consortium tackles genetic origins of neurodevelopmental and psychiatric disorders

Neurodevelopmental and psychiatric disorders (NPD) including schizophrenia, bipolar disorder, autism, and depression are detrimental to individuals, their families and society as a whole, and in many cases still lack effective treatments.

12 Sep 2024

COVID-19 vaccines prevented millions of deaths across Latin America and the Caribbean, study shows

Researchers estimate that COVID-19 vaccines averted between 610,000 and 2.62 million deaths in select Latin American and Caribbean countries from early 2021 to May 2022.

12 Sep 2024

No difference in health outcomes between 24-hour and 15-hour oxygen therapy

There were no differences in quality of life, symptoms, hospital admissions or mortality between a group of patients with pulmonary disease and low oxygen levels in the blood that received oxygen therapy at home for 24 hours a day, and a group that received the same therapy for 15 hours a day, according to a study from Lund University in Sweden.

12 Sep 2024

Cannabidiol shows promise in treating cognitive disorders

Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.

12 Sep 2024

Current and emerging biomarkers in the management of inflammatory bowel disease

Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disorder of the gastrointestinal (GI) tract that significantly impacts the quality of life of patients.

12 Sep 2024

New study links lower Nutri-score foods to increased cardiovascular risk

Cardiovascular diseases are the leading cause of mortality in Western Europe, accounting for 1/3 of deaths in 2019.

12 Sep 2024

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged.

12 Sep 2024

Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.

12 Sep 2024

Fear of hypoglycemia limits physical activity in adults with type 1 diabetes

Despite high use of continuous glucose monitoring and insulin pump therapy, fear of hypoglycemia (low blood sugar) remains a significant barrier to physical activity and exercise for adults with type 1 diabetes (T1D), according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

12 Sep 2024

New AI imaging technique enhances retinal disorder diagnosis

Previous
1
...
65
66
67
68
69
70
71
...
5486
Next

Medical Condition News

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Melanoma incidence and mortality may eventually decrease among the entire Swedish population

Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Significant global cardiovascular risk linked to high lipoprotein(a) levels

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

New gene variants linked to early menopause and cancer risk identified

New consortium tackles genetic origins of neurodevelopmental and psychiatric disorders

COVID-19 vaccines prevented millions of deaths across Latin America and the Caribbean, study shows

No difference in health outcomes between 24-hour and 15-hour oxygen therapy

Cannabidiol shows promise in treating cognitive disorders

Current and emerging biomarkers in the management of inflammatory bowel disease

New study links lower Nutri-score foods to increased cardiovascular risk

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers

Fear of hypoglycemia limits physical activity in adults with type 1 diabetes

New AI imaging technique enhances retinal disorder diagnosis

New discovery offers hope for overcoming CAR-T cell therapy resistance

Prolonged exposure to wildfire smoke increases mental illness risk in youth

B cell abnormalities identified as potential biomarkers for triple negative breast cancer treatment response

Study reveals 45% drop in oxycodone use in Australia after policy changes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News